Across the recent three months, 5 analysts have shared their insights on Molina Healthcare (NYSE:MOH), expressing a variety of opinions spanning from bullish to bearish.

The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.

In the assessment of 12-month price targets, analysts unveil insights for Molina Healthcare, presenting an average target of $420.6, a high estimate of $460.00, and a low estimate of $380.00. Surpassing the previous average price target of $381.50, the current average has increased by 10.25%.

Decoding Analyst Ratings: A Detailed Look

The standing of Molina Healthcare among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Key Insights:

Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Molina Healthcare's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.

Stay up to date on Molina Healthcare analyst ratings.

All You Need to Know About Molina Healthcare

Molina Healthcare: Delving into Financials

Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.

Revenue Growth: Molina Healthcare displayed positive results in 3 months. As of 31 December, 2023, the company achieved a solid revenue growth rate of approximately 10.03%. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Health Care sector.

Net Margin: Molina Healthcare's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.39% net margin, the company effectively manages costs and achieves strong profitability.

Return on Equity (ROE): Molina Healthcare's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 5.34% ROE, the company effectively utilizes shareholder equity capital.

Return on Assets (ROA): Molina Healthcare's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.45% ROA, the company effectively utilizes its assets for optimal returns.

Debt Management: With a high debt-to-equity ratio of 0.57, Molina Healthcare faces challenges in effectively managing its debt levels, indicating potential financial strain.

Analyst Ratings: Simplified

Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.

Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.

If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in Benzinga Pro.

This article was generated by Benzinga's automated content engine and reviewed by an editor.